BKYI - Company ID 0001019034
The table below shows BIO KEY INTERNATIONAL INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $2.15M | $1.55M | $1.70M | $1.61M | $2.14M | $1.14M |
| Cost of revenue | $376.30K | $357.99K | $464.18K | $279.50K | $465.11K | $262.27K |
| Gross profit | $1.77M | $1.19M | $1.23M | $1.33M | $1.68M | $879.01K |
| R&D | $616.88K | $683.62K | $636.03K | $595.77K | $652.17K | $591.23K |
BIO KEY INTERNATIONAL INC reported annual revenue of $5.94M for fiscal year 2025. That is down 14.3% from $6.93M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $2.98M (FY 2016) to $5.94M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $1.31M | $1.40M | $1.68M | $1.37M | $1.61M | $1.94M |
| Operating income | -$157.71K | -$892.19K | -$1.08M | -$640.64K | -$580.40K | -$1.65M |
| Income tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | -$205.04K | -$964.85K | -$1.17M | -$736.54K | -$738.96K | -$1.67M |
| EPS (diluted) | - | - | - | - | - | - |